1. Doxorubicin: nanotechnological overviews from bench to bedside;Cagel;Drug Discov Today,2017
2. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA;Bodley;Cancer Res,1989
3. Doxorubicin cardiotoxicity and target cells: a broader perspective;De Angelis;Cardio-Oncol,2016
4. Activation of nuclear factor kappaB through the IKK complex by the topoisomerase poisons SN38 and doxorubicin: a brake to apoptosis in HeLa human carcinoma cells;Bottero;Cancer Res,2001
5. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB;Wang;Science,1996